SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " mifepristone " 24 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Supreme Court temporarily restores access to abortion pill mifepristone through telehealth, mail and pharmacies
The court's order will remain in effect for another week while both sides respond and the court more fully considers the issue.
Indiana attorney general targets abortion pill mifepristone as water risk. Health experts dispute the claim
Indiana’s Attorney General joined 13 other states to call for the EPA to classify the abortion inducing drug mifepristone as a water contaminant, arguing it could pose a health risk. Health experts say there’s no evidence for his claims.
F.D.A. Decisions on Abortion Pill Were Based on Science, New Analysis Finds
A study of more than 5,000 pages of agency documents on mifepristone over 12 years found that agency leaders almost always followed the evidence-based recommendations of scientists.
Expert explains the science, safety, and legal landscape around mifepristone used in abortions, miscarriage care
The U.S. Supreme Court has preserved access to mifepristone—the medication used in the majority of abortions in the United States and in some miscarriage care—for now. The action maintains current rules ...
KFF Health Tracking Poll: Mifepristone and the Midterms
Amid an ongoing FDA re-review of mifepristone, awareness of the safety and prevalence of the abortion pill remains limited. This KFF poll also finds that the voters who say abortion policy is an important issue for 2026 midterm candidates to discuss are disproportionately Democrats.
Abortion pills to be offered at California community college health centers under new law
Gov. Newsom has signed a law requiring most community colleges to offer abortion medication as of 2029. Public universities in California already do.
Anger Over Health Costs Clouds Midterms
Amid a campaign already focusing on affordability, anxious voters are unlikely to be assuaged by headlines about healthcare costs rising even more next year. And a lawsuit that could cut off access nationwide to the abortion pill mifepristone gets a hearing in federal court. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Sandhya Raman of Bloomberg Law, and Amanda Seitz of KFF Health News join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner also interviews Lauren Sausser, who wrote the latest KFF Health News “Bill of the Month.”
The Court Ruling That Just Exposed a Hidden Risk in Modern Business Strategy
A single court decision just broke a core business assumption. Here’s why every leader should be paying attention.
Supreme Court abortion case could force Trump to take a public stance on mifepristone
The return of abortion to the Supreme Court is testing President Donald Trump’s strategy of avoiding the issue as the anti-abortion advocates grow increasingly frustrated that his administration hasn’t done more to crack down on access to mifepristone, the drug approved to terminate pregnancies.
Supreme Court extends mifepristone deadline
The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds
The Mifepristone Ruling Revives Pro-Choice Politics
A federal court’s ban on the mailing of abortion medication once again demonstrates the unpopularity of anti-abortion zealotry.
Supreme Court temporarily restores ability to receive abortion drug mifepristone by mail
The Supreme Court temporarily restored telehealth and mail access to the abortion pill mifepristone on Monday, responding to an emergency appeal that warned of potential chaos for patients who had appointments to access the drug.
Trump nominates anti-abortion White House aide as next FDA commissioner
If confirmed by the Senate, Heidi Overton, MD, PhD, would replace Marty Makary, MD, who resigned in May. Overton, who is associated with the America First Policy Institute, is an outspoken opponent of the abortion drug mifepristone.
Abortion Pill’s Safety Called into Question in Congressional Actions Based on Misleading Data — The Monitor
False claims about the safety of mifepristone are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safety. And competing interpretations of what censorship and free speech mean are impacting how health misinformation is moderated.
Supreme Court temporarily extends access to a widely used abortion pill
The Supreme Court is leaving women’s access to a widely used abortion pill untouched until at least Thursday, while the justices consider whether to allow restrictions on the drug, mifepristone, to take effect.
KFF Health Tracking Poll: Knowledge and Views of Medication Abortion
This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.
What The Abortion Pill Case Could Mean For The Workforce And Healthcare
A federal appeals court said providers could no longer mail mifepristone anywhere in the country. SCOTUS temporarily restored access for mailing the drug until May 14th.
Abortion Pill Politics
A federal court’s decision to override the FDA and restrict availability of the abortion pill mifepristone has launched abortion back into the national
Abortion reemerges as election issue amid challenges to mifepristone
On Friday, the Supreme Court temporarily blocked a federal appeals court ruling that would have prevented the abortion pill mifepristone from being mailed.
The connection between periods and mental health
Plans to oust Makary, a looming Supreme Court deadline on mifepristone, and other health news from Morning Rounds
Fight over online access to abortion pill reaches Supreme Court in emergency appeal
The makers of the abortion pill mifepristone filed an emergency appeal at the Supreme Court on Saturday urging the justices to pause a lower-court ruling that temporarily blocked Americans from accessing the drug through the mail.
Supreme Court preserves access to widely used abortion pill, while lawsuit plays out
The court’s order allows women seeking abortions to continue obtaining the drug, mifepristone, at pharmacies or through the mail, without an in-person visit to a doctor. Access is likely to remain uninterrupted at least until into next year as the case plays out, including a potential appeal to the high court.
In-person requirements for abortion medication headed to Kim Reynolds
A bill awaiting Gov. Kim Reynolds' signature says Iowans would have to see a doctor in person to receive abortion medications such as mifepristone.
Trump's FDA boss resigning as admin taps next acting leader
FDA Commissioner Marty Makary resigns after clashes over the abortion drug mifepristone and mounting pro-life group frustrations.